A similar trend was also seen for GRP78, ATF4, ATF6 and XBP1s expression after CDNF-treatment, although the data did not reach statistical significance (Fig. 11 B).
← all excerpts
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease.
1
—
—